Giovanni Faga'

Title: Giovanni Faga': Innovator in E3 Ligase Inhibition

Introduction

Giovanni Faga' is a notable inventor based in Milan, Italy. He has made significant contributions to the field of molecular oncology through his innovative research and patenting activities. His work primarily focuses on the development of inhibitors for HECT-domain-containing E3 ligases, which play a crucial role in various cellular processes.

Latest Patents

Faga' holds a patent for "HECT E3 ligase inhibitors and uses thereof." This invention relates to tricyclic derivatives of a specific formula, which are useful as inhibitors of HECT-domain-containing E3 ligases, particularly NEDD4. The patent also encompasses pharmaceutical compositions that include these compounds, their medical applications, and the processes for their preparation. He has 1 patent to his name.

Career Highlights

Throughout his career, Giovanni Faga' has worked with prominent research institutions, including the IFOM (Fondazione Istituto Firc Di Oncologia Molecolare) and the IEO (Istituto Europeo Di Oncologia S.r.l.). His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Faga' has collaborated with esteemed colleagues such as Sebastiano Pasqualato and Maurizio Pasi. These collaborations have further enriched his research endeavors and have led to significant advancements in the field of oncology.

Conclusion

Giovanni Faga' is a distinguished inventor whose work on E3 ligase inhibitors has the potential to impact the treatment of various diseases. His contributions to molecular oncology and his collaborations with leading researchers highlight his importance in the scientific community.